GlaxoSmithKline's total assets for Q3 2025 were £61.34B, an increase of 3.51% from the previous quarter. GB:GSK total liabilities were £45.59B for the fiscal quarter, a 1.52% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.